Project

BioGelator for local immunotherapy

Acronym
BioBoost
Code
F2021/IOF-StarTT/068
Duration
15 July 2021 → 14 January 2023
Funding
Regional and community funding: Industrial Research Fund
Research disciplines
  • Medical and health sciences
    • Biopharmaceuticals
    • Cancer therapy
  • Engineering and technology
    • Biomaterials
    • Biomaterials engineering not elsewhere classified
Keywords
excipient cancer immunotherapy
 
Project description

Local administration of immunotherapeutics is burdened by low bio-availability. BioBoost is a technical solution that facilitates the interaction between these compounds and the immune cells of interest. In this way, BioBoost can be commercialized as a complementary technology for companies with a pipeline of novel immunotherapeutics.